Protected: Creating a more affordable and efficient vaccine development platform
June 21, 2022
Health Awareness June 21, 2022
Protected: Creating a more affordable and efficient vaccine development platform…
This Company has its Sights Set of Transforming the Pharmaceutical Industry With its Efficient C1 Vaccine & Drug Manufacturing Technology
November 1, 2021
Benzinga November 1, 2021
This Company has its Sights Set of Transforming the Pharmaceutical Industry With its Efficient C1 Vaccine & Drug Manufacturing Technology…
The Vaccine Revolution Portfolio (MRNA, PFE, JNJ, NVAX, BNTX, AZN, DYAI)
September 9, 2021
Wall Street September 8, 2021
The Vaccine Revolution Portfolio (MRNA, PFE, JNJ, NVAX, BNTX, AZN, DYAI)…
Desperation on Variants Paints Path for Long-Term Vaccine Thesis (DYAI, MRNA, PFE, JNJ, NVAX, BNTX, AZN, SRNE)
September 7, 2021
Wall Street August 31, 2021
Desperation on Variants Paints Path for Long-Term Vaccine Thesis (DYAI, MRNA, PFE, JNJ, NVAX, BNTX, AZN, SRNE)…
Moderna bounces back with spotlight on other vaccine stocks (MRNA, DYAI, NVAX, JNJ, AZN, BNTX, PFE)
August 16, 2021
Wall Street August 12, 2021
Moderna bounces back with spotlight on other vaccine stocks (MRNA, DYAI, NVAX, JNJ, AZN, BNTX, PFE)…
The Covid Vaccine Market is a Long Game in the Early Innings (BNTX, AZN, DYAI, NVAX, MRNA, PFE, JNJ)
August 9, 2021
Wall Street August 4, 2021
The Covid Vaccine Market is a Long Game in the Early Innings (BNTX, AZN, DYAI, NVAX, MRNA, PFE, JNJ)…
Dyadic Int’l (DYAI) Inks Deal Toward Potential Access to 40% of the World as Covid Vaccine Continues in Development
July 30, 2021
Wall Street July 28, 2021
Dyadic Int’l (DYAI) Inks Deal Toward Potential Access to 40% of the World as Covid Vaccine Continues in Development…
Delta Means Beta Testing Alpha Strategies in Biotech (NVAX, MRNA, DYAI, PFE, JNJ, BNTX, AZN, IBB)
July 22, 2021
MarketWatch July 22, 2021
Delta Means Beta Testing Alpha Strategies in Biotech (NVAX, MRNA, DYAI, PFE, JNJ, BNTX, AZN, IBB)…
Dyadic applies novel C1 vaccine manufacturing platform based on Thermothelomyces fungus to develop vaccines & drugs against the coronavirus and emerging variants
July 19, 2021
USA Today Special Edition July 19, 2021
See page 61 for: Dyadic applies novel C1 vaccine manufacturing platform based on Thermothelomyces fungus to develop vaccines & drugs against the coronavirus and emerging variants
For pdf click HERE…
Emerging Themes in the COVID-19 Vaccine Space (MRNA, PFE, DYAI, JNJ, NVAX, BNTX, AZN)
July 15, 2021
MarketWatch July 13, 2021
Emerging Themes in the COVID-19 Vaccine Space (MRNA, PFE, DYAI, JNJ, NVAX, BNTX, AZN)…
Dyadic International (NASDAQ: DYAI): A Unique Approach to World Vaccination (DYAI, AZN, MRNA, NVAX, PFE, JNJ, BNTX)
June 14, 2021
MarketWatch June 9, 2021
Dyadic International (NASDAQ: DYAI): A Unique Approach to World Vaccination (DYAI, AZN, MRNA, NVAX, PFE, JNJ, BNTX)…
Off Message: Dyadic Fights Covid-19 with a Fungus
June 8, 2021
GENEDGE June 8, 2021
Off Message: Dyadic Fights Covid-19 with a Fungus…
The Vaccine Investment Hypothesis, and What’s Next (AZN, JNJ, DYAI, BNTX)
June 3, 2021
MarketWatch June 2, 2021
The Vaccine Investment Hypothesis, and What’s Next (AZN, JNJ, DYAI, BNTX)…
Leading Vaccine Stocks Under the Microscope (PFE, NVAX, DYAI, MRNA)
May 27, 2021
MarketWatch May 26, 2021
Leading Vaccine Stocks Under the Microscope (PFE, NVAX, DYAI, MRNA)…
Could Dyadic International (DYAI) be a Dark Horse Vaccine MVP
May 20, 2021
StreetInsider.com May 20, 2021
Could Dyadic International (DYAI) be a Dark Horse Vaccine MVP…
DYAI’s C1 Technology May be Key in the Race to Vaccine-Induced Herd Immunity
May 18, 2021
Wall Street May 12, 2021
DYAI’s C1 Technology May be Key in the Race to Vaccine-Induced Herd Immunity…
Elsevier Biologicals April 2021
May 17, 2021
Elsevier Biologicals April 2021
Can a fungal platform be faster and cheaper than other platforms, enabling many cheaper and quicker therapeutics? Joris Vandeputte responded that the ZAPI experience shows that the fungal C1 system is a high-performance system, which can produce high quantities of apparently excellent antigens, in the appropriate conformation, and well glycosylated, which has been confirmed in animal…
Time for a New Vaccine Production Model? Spotlight on DYAI (NASDAQ: DYAI)
April 28, 2021
MarketWatch April 28, 2021
Time for a New Vaccine Production Model? Spotlight on DYAI (NASDAQ: DYAI)…
DYAI in Focus: Upstart Vaccine Maker says has Faster Way to Vaccinate the World
April 20, 2021
Journal Transcript April 20, 2021
DYAI in Focus: Upstart Vaccine Maker Says has Faster Way to Vaccinate the World (AZN, MRNA, NVAX, PFE, JNJ, BNTX)…
Is Dyadic International Inc the Key to the Next Wave of Vaccines?
April 9, 2021
StreetInsider.com April 9, 2021
Is Dyadic International Inc. (NASDAQ: DYAI) the Key to the Next Wave of Vaccinations? (NASDAQ: AZN) (NASDAQ: MRNA) (NYSE: PFE) (NASDAQ: NVAX)…
How Dyadic International Inc Fits into the Vaccine 2.0 Gold Rush
April 1, 2021
MarketWatch April 1, 2021
How Dyadic International Inc (NASDAQ: DYAI) Fits into the Vaccine 2.0 Gold Rush (NASDAQ: BNTX) (NYSE: JNJ) (NASDAQ: MRNA) (NYSE: PFE)…
Is Dyadic International Inc the Key to Scaling up Global Access to a Viable Covid-19 Vaccine?
March 30, 2021
StreetInsider.com March 30, 2021
Is Dyadic International Inc. (NASDAQ: DYAI) the Key to Scaling Up Global Access to a Viable Covid-19 Vaccine? (NASDAQ: NVAX) (NASDAQ: MRNA) (NYSE: PFE) (NASDAQ: AZN)…
A recipe for the next disaster: a new, pan-virus methodology for ramping up vaccine production
March 24, 2021
Innovative Medicines Initiative March 24, 2021
A recipe for the next disaster: a new, pan-virus methodology for ramping up vaccine production
ZAPI have put in place a new pan-virus methodology for ramping up the production of new vaccines in the next crisis…
Covid-19 Pandemic Still Fueling Need for Increased Supplies & New Technology in PPE Markets
March 23, 2021
FinancialNewsMedia.com March 23, 2021
Covid-19 Pandemic Still Fueling Need for Increased Supplies & New Technology in PPE Markets…
Dyadic Biotechnology Is On A Quest To Find A Solution For COVID-19
December 10, 2020
Benzinga – Silvia Munoz Campo, December 10, 2020
Dyadic Biotechnology Is On A Quest To Find A Solution For COVID-19…
Dyadic International, Inc. The Global Quest for A Vaccine Drives Dyadic’s C1 Adoption
August 11, 2020
SNN / MicroCap Review Magazine Summer 2020
The Global Quest for A Vaccine Drives Dyadic’s C1 Adoption…
Dyadic and Frederick National Laboratory to develop C1 cell lines for COVID-19
June 10, 2020
Proactive Investors, June 10, 2020
Dyadic and Frederick National Laboratory to develop C1 cell lines for coronavirus vaccine candidates…
Studying animal coronavirus defences is opening route to human treatments
April 7, 2020
Horizon, the EU Research & Innovation Magazine, April 7, 2020
Studying animal coronavirus defences is opening route to human treatments…
ZAPI is laying the groundwork for the response to zoonotic disease outbreaks like COVID-19
March 30, 2020
Innovative Medicines Initiative, March 30, 2020
ZAPI is laying the groundwork for the response to zoonotic disease outbreaks like COVID-19…
Quicker, cheaper, better is Dyadic’s motto
January 22, 2020
Animal Pharm Agribusiness, January 21, 2020
Quicker, cheaper, better is Dyadic motto…
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system
August 16, 2019
BioProcess International, August 16, 2019
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system…
FDA should improve incentives to lower drug costs, says Dyadic CEO
July 8, 2019
BioPharma-Reporter.com July 2, 2019
FDA should improve incentives to lower drug costs, says Dyadic CEO…
DYAI Looking Increasingly Compelling
February 24, 2019
Tailwinds Research Group February 21, 2019
DYAI Looking Increasingly Compelling…
The shutdown is over – but not the pain for small businesses
January 31, 2019
NBC News January 31, 2019
The shutdown is over – but not the pain for small businesses…
Is the Production of Biologic Drugs Ready for an Overhaul?
January 30, 2019
Manufacturing Chemist, January 30, 2019
Is the Production of Biologic Drugs Ready for an Overhaul?…
Stuck in shutdown limbo, companies put IPOs on hold
January 23, 2019
The Washington Post, January 23, 2019
Stuck in shutdown limbo, companies put IPOs on hold…
Looking Beyond Mammals to Microbes for Tomorrow’s Drugs
January 11, 2019
DGIwire January 11, 2019
Looking Beyond Mammals to Microbes for Tomorrow’s Drugs…
Going Beyond CHO
December 13, 2018
EuroLab Magazine, ScientistLive December 2018
Going Beyond CHO…
Is a Fungus Among Us the Key to Tomorrow’s Biologic Drugs?
December 3, 2018
DGIwire December 3, 2018
Is a Fungus Among Us the Key to Tomorrow’s Biologic Drugs?…
Building Better Biologics: A Challenge for the Biopharma Industry
November 26, 2018
DGIwire November 26, 2018
Building Better Biologics: A Challenge for the Biopharma Industry…
Protein expression, revisited
November 16, 2018
Science, November 16, 2018
Protein expression, revisited…
Fungal Strain Technology Could Disrupt Bio-Manufacturing Industry
November 5, 2018
R&D Magazine / Pharmaceutical Processing, November 5, 2018
Fungal Strain Technology Could Disrupt Bio-Manufacturing Industry…
Media Requirements for Different Cell Sources
November 1, 2018
BioPharm International, November 1, 2018
Media Requirements for Different Cell Sources…
Dyadic International: Working to Change the Game in Biopharma Manufacturing
October 10, 2018
LSX Leaders (formerly known as BiotechandMoney), October 2018
Dyadic International: Working to Change the Game in Biopharma Manufacturing…
Biologic Drugs Challenge the Biopharma Industry
October 8, 2018
PharmTech.com, October 5, 2018
Biologic Drugs Challenge the Biopharma Industry…
Undervalued Stocks You Can’t Afford to Miss
October 4, 2018
Yahoo Finance, October 4, 2018
Undervalued Stocks You Can’t Afford to Miss…
CHO Cells: Beginning of the End or End of the Beginning?
September 27, 2018
Biocompare, September 27, 2018
CHO Cells: Beginning of the End or End of the Beginning?…
Ditching the Model T for a Faster Ride
September 26, 2018
Pharmaceutical Manufacturing, September 25, 2018
Ditching the Model T for a Faster Ride…
CHO cells the 1900s model car in a 2020 Tesla world, says Dyadic
September 24, 2018
BioPharma-Reporter.com, September 24, 2018
CHO cells the 1900s model car in a 2020 Tesla world, says Dyadic…
The CHO’s Over: An Inflexion Point
September 18, 2018
The Medicine Maker magazine, September 2018
The CHO’s Over: An Inflexion Point…